Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies

CNS Neuroscience & Therapeutics
J L CummingsAmitabh Dash

Abstract

Alzheimer's disease (AD) is a progressive condition that affects cognition, function, and behavior. Approximately 60-90% of patients with AD develop neuropsychiatric symptoms (NPS) such as hallucinations, delusions, agitation/aggression, dysphoria/depression, anxiety, irritability, disinhibition, euphoria, apathy, aberrant motor behavior, sleep disturbances, appetite and eating changes, or altered sexual behavior. These noncognitive behavior changes are thought to result from anatomical and biochemical changes within the brain, and have been linked, in part, to cholinergic deficiency. Cholinesterase inhibitors may reduce the emergence of NPS and have a role in their treatment. These agents may delay initiation of, or reduce the need for, other drugs such as antipsychotics. This article summarizes the effects of donepezil, a cholinesterase inhibitor, on the NPS of dementia with emphasis on AD and dementia with Lewy bodies.

References

May 1, 1989·Journal of Gerontology·J Cohen-MansfieldA S Rosenthal
Nov 1, 1984·The American Journal of Psychiatry·W G RosenK L Davis
Sep 16, 1998·Clinical Therapeutics·G W SmallR L Brooks
Dec 16, 1998·Dementia and Geriatric Cognitive Disorders·S L Rogers
Aug 29, 2001·Neurology·H FeldmanUNKNOWN Donepezil MSAD Study Investigators Group
May 8, 2002·International Journal of Geriatric Psychiatry·Michal Schnaider BeeriShlomo Noy
Nov 22, 2002·Current Medical Research and Opinion·S GauthierUNKNOWN Donepezil MSAD Study Investigators' Group
Nov 29, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Brian Lawlor
Nov 29, 2002·Gerontology·Afina W LemstraWillem A van Gool
Dec 7, 2002·Clinical Neuropharmacology·Diana PaleacuYoram Barak
Apr 3, 2003·Clinical Neuropharmacology·Joseph BergmanVladimir Lerner
Jul 2, 2004·The New England Journal of Medicine·Jeffrey L Cummings
Sep 1, 2004·Expert Opinion on Drug Safety·Sarah ThompsonNathan Herrmann
Feb 3, 2005·JAMA : the Journal of the American Medical Association·Kaycee M SinkKristine Yaffe
Feb 9, 2005·CNS Drugs·Nathan Herrmann, Krista L Lanctôt
May 28, 2005·International Journal of Geriatric Psychiatry·Howard FeldmanUNKNOWN Donepezil MSAD Study Investigators Group
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Lon S SchneiderPhilip Insel
Nov 22, 2005·Mechanisms of Ageing and Development·Alessia LanariLucilla Parnetti
Apr 4, 2006·Lancet·Bengt WinbladUNKNOWN Severe Alzheimer's Disease Study Group
Jul 4, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Jeffrey L CummingsUNKNOWN Donepezil-Sertraline Study Group
Sep 9, 2009·Current Medical Research and Opinion·Bengt WinbladKenneth Albert
Feb 17, 2010·Neuropharmacology·Paul T FrancisMitchell K Lai
Oct 6, 2010·BMC Neurology·Manuel FernándezUNKNOWN COOPERA Study Group
Mar 15, 2011·Alzheimer Disease and Associated Disorders·Manuel Martin CarrascoTeresa Leon
May 17, 2011·The American Journal of Psychiatry·Cheryl L P VigenLon S Schneider
Jul 26, 2012·Annals of Neurology·Etsuro MoriUNKNOWN Donepezil-DLB Study Investigators
Feb 16, 2013·Journal of Alzheimer's Disease : JAD·Simona Gabriella Di SantoMassimo Musicco
Aug 21, 2013·Dementia and Geriatric Cognitive Disorders·Manabu IkedaUNKNOWN Donepezil-DLB Study Investigators
Dec 18, 2014·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Katsuyuki UkaiNorio Ozaki
Feb 26, 2015·Alzheimer's Research & Therapy·Manabu IkedaKenji Kosaka
Jul 17, 2015·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Yuta ManabeKenji Kosaka

❮ Previous
Next ❯

Citations

Jan 24, 2019·Current Treatment Options in Neurology·Kasia Gustaw Rothenberg, Ryan Rajaram
Sep 4, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Guogen ShanJeffrey L Cummings
May 3, 2020·International Journal of Molecular Sciences·Ramon Cacabelos
Jun 11, 2020·Expert Opinion on Drug Metabolism & Toxicology·Ramón Cacabelos
Jun 1, 2018·Continuum : Lifelong Learning in Neurology·M Uri WolfMorris Freedman
Jul 26, 2019·Current Geriatrics Reports·Cara L McDermott, David A Gruenewald
Oct 19, 2017·Human Molecular Genetics·Hiroyuki MiyamotoKazuhiro Yamakawa
Jun 6, 2018·Journal of Alzheimer's Disease : JAD·Alberto Llorente-OvejeroRafael Rodríguez-Puertas
May 18, 2019·Drugs in R&D·Stephanie V PhanSusan C Fagan
Jan 13, 2017·Current Opinion in Psychiatry·Orestes V ForlenzaFlorindo Stella
Jul 11, 2018·Neurology and Therapy·Samuel D CapouchJared R Brosch
Aug 10, 2020·International Ophthalmology·Aldo VaggeCarlo Enrico Traverso
Feb 23, 2017·Journal of Alzheimer's Disease : JAD·Sachiko NakayamaNobutaka Hattori
May 28, 2016·Expert Opinion on Investigational Drugs·Ricardo P GarayPierre-Michel Llorca
Mar 13, 2018·Current Opinion in Psychiatry·Iris E SommerKenneth Hugdahl
Jul 25, 2019·Neurología : publicación oficial de la Sociedad Española de Neurología·A Robles Bayón
Jan 12, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Hussein AkelIldikó Csóka
Jun 2, 2020·Parkinsonism & Related Disorders·Kevin Kyle, Jeff M Bronstein
Jul 30, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Joachim MazèreWilly Mayo
May 25, 2021·Yonago Acta Medica·Shinya Takeda, Toshiki Fukuzaki
Jul 4, 2021·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Wenqi LüWeihua Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
Kelly Reilly KroustosKristen Finley Sobota
Dementia & Neuropsychologia
Lyssandra Dos Santos Tascone, Cássio Machado de Campos Bottino
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
J L Cummings, C Back
© 2022 Meta ULC. All rights reserved